Drug intelligence / Profile preview

puberulic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Subcutaneous
01

Overview

**Puberulic acid** is a highly oxygenated tropolone derivative (C8H6O6; MW: 198.13) produced as a secondary metabolite by several Penicillium species, including Penicillium puberulum and Penicillium aurantiovirens[2][4][8]. It has been investigated as a potential **antimalarial** agent due to potent in vitro and in vivo efficacy against Plasmodium falciparum and other malaria parasites, with an IC50 as low as 0.044–0.05 μM[5][6][10]. However, puberulic acid is also strongly cytotoxic, causing nephrotoxicity (renal proximal tubule injury) in animal models and cultured human renal cells, and has been implicated in cases of food poisoning due to contamination of red yeast rice supplements[1][3][7]. Its cytotoxicity appears connected to inhibition/interaction with organic anion transporters (OAT1), interfering with renal cell transport functions[1]. Efforts are underway to develop less toxic derivatives for therapeutic use[5][3].

Other names
puberulic acidpuberulonate
02

Targets

MIOXSLC5A11 (Sodium-coupled myo-inositol transporter 2 (SMIT2))SLC5A3 (Sodium/myo-inositol cotransporter 1 (SMIT1))

Beyond the preview

Go deeper on puberulic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on puberulic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call